|
Volumn 10, Issue 2, 2001, Pages 185-195
|
Long-term results with St. Jude Medical and CarboMedics prosthetic heart valves
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
FIBRINOLYTIC AGENT;
WARFARIN;
ADOLESCENT;
ADULT;
AGED;
ANTICOAGULANT THERAPY;
AORTA VALVE REPLACEMENT;
ARTICLE;
BLEEDING;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HEART VALVE PROSTHESIS;
HEART VALVE REPLACEMENT;
HUMAN;
INCIDENCE;
INFANT;
INTERMETHOD COMPARISON;
INTRACARDIAC THROMBOSIS;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL ASSESSMENT;
MITRAL VALVE REPLACEMENT;
MORTALITY;
PATIENT MONITORING;
POSTOPERATIVE CARE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PROSTHESIS FAILURE;
SAINT JUDE HEART VALVE PROSTHESIS;
STATISTICAL ANALYSIS;
SURGICAL TECHNIQUE;
SURVIVAL RATE;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
TRICUSPID VALVE;
ADOLESCENT;
ADULT;
AGED;
CHILD;
CHILD, PRESCHOOL;
EQUIPMENT FAILURE ANALYSIS;
FEMALE;
HEART VALVE DISEASES;
HEART VALVE PROSTHESIS;
HEART VALVES;
HOSPITAL MORTALITY;
HUMANS;
INFANT;
MALE;
MIDDLE AGED;
SURVIVAL RATE;
THROMBOEMBOLISM;
TIME FACTORS;
|
EID: 0035077270
PISSN: 09668519
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (22)
|
References (23)
|